Osteoarthritis year in review 2015: biology.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 26707989)

Published in Osteoarthritis Cartilage on January 01, 2016

Authors

A M Malfait1

Author Affiliations

1: Department of Internal Medicine, Division of Rheumatology, Rush University Medical Center, Chicago, IL, USA; Department of Biochemistry, Rush University Medical Center, Chicago, IL, USA. Electronic address: annemarie@annemariemalfait.com.

Articles citing this

Progranulin: A key player in autoimmune diseases. Cytokine (2016) 0.83

Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res (2017) 0.80

Diet-Intestinal Microbiota Axis in Osteoarthritis: A Possible Role. Mediators Inflamm (2016) 0.76

Are estrogen-related drugs new alternatives for the management of osteoarthritis? Arthritis Res Ther (2016) 0.76

Functional Tissue Analysis Reveals Successful Cryopreservation of Human Osteoarthritic Synovium. PLoS One (2016) 0.75

Oral Administration of Resveratrol Alleviates Osteoarthritis Pathology in C57BL/6J Mice Model Induced by a High-Fat Diet. Mediators Inflamm (2017) 0.75

T Cells in Osteoarthritis: Alterations and Beyond. Front Immunol (2017) 0.75

Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res (2016) 0.75

Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1. PLoS One (2016) 0.75

Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB. Arthritis Res Ther (2017) 0.75

Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway. Sci Rep (2016) 0.75

Dietary intake of fiber in relation to knee pain trajectories. Arthritis Care Res (Hoboken) (2016) 0.75

Matriptase induces metalloproteinase-dependent aggrecanolysis in vitro and in vivo: multiple mechanisms promote cartilage damage in osteoarthritis. Arthritis Rheumatol (2017) 0.75

Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain. Ther Clin Risk Manag (2017) 0.75

Crocin Attenuates Joint Pain and Muscle Dysfunction in Osteoarthritis Rat. Inflammation (2017) 0.75

Articles cited by this

The hallmarks of aging. Cell (2013) 14.29

Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28

Inflammation in osteoarthritis. Curr Opin Rheumatol (2011) 2.72

The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37

Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytes. Arthritis Rheumatol (2014) 2.09

Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell (2014) 1.86

The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol (2014) 1.64

OARSI-FDA initiative: defining the disease state of osteoarthritis. Osteoarthritis Cartilage (2011) 1.59

Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum (2012) 1.30

Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford) (2014) 1.21

Aging processes and the development of osteoarthritis. Curr Opin Rheumatol (2013) 1.18

Autophagy: a druggable process that is deregulated in aging and human disease. J Clin Invest (2015) 1.18

Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol (2013) 1.15

Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol (2014) 1.15

A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee. Osteoarthritis Cartilage (2015) 1.12

Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther (2014) 1.10

Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther (2014) 1.04

Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol (2013) 1.04

Structural associations of symptomatic knee osteoarthritis. Arthritis Rheumatol (2014) 1.02

Induction of nerve growth factor expression and release by mechanical and inflammatory stimuli in chondrocytes: possible involvement in osteoarthritis pain. Arthritis Res Ther (2014) 1.00

Peripheral calcitonin gene-related peptide receptor activation and mechanical sensitization of the joint in rat models of osteoarthritis pain. Arthritis Rheumatol (2014) 0.98

Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury. Ann Rheum Dis (2014) 0.96

Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1. Arthritis Rheumatol (2014) 0.95

Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas (2014) 0.95

A homeostatic function of CXCR2 signalling in articular cartilage. Ann Rheum Dis (2014) 0.93

On the predictive utility of animal models of osteoarthritis. Arthritis Res Ther (2015) 0.93

PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis (2015) 0.92

FoxO transcription factors support oxidative stress resistance in human chondrocytes. Arthritis Rheumatol (2014) 0.92

The relationship of autophagy defects to cartilage damage during joint aging in a mouse model. Arthritis Rheumatol (2015) 0.91

Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms. Arthritis Rheumatol (2014) 0.91

Dysregulated FOXO transcription factors in articular cartilage in aging and osteoarthritis. Osteoarthritis Cartilage (2013) 0.91

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthritis Cartilage (2014) 0.90

Treatment efficacy of adipose-derived stem cells in experimental osteoarthritis is driven by high synovial activation and reflected by S100A8/A9 serum levels. Osteoarthritis Cartilage (2014) 0.89

TGF-β is a potent inducer of Nerve Growth Factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain? Osteoarthritis Cartilage (2014) 0.88

Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase. Arthritis Rheumatol (2014) 0.87

Peroxisome proliferator-activated receptor δ promotes the progression of posttraumatic osteoarthritis in a mouse model. Arthritis Rheumatol (2015) 0.85

Bioactivity in an Aggrecan 32-mer Fragment Is Mediated via Toll-like Receptor 2. Arthritis Rheumatol (2015) 0.83

Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat. Neuroscience (2015) 0.82

Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine (2014) 0.81

Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice. Osteoarthritis Cartilage (2014) 0.81

Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Osteoarthritis Cartilage (2015) 0.80

Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain. Curr Opin Support Palliat Care (2015) 0.79

Life-long caloric restriction does not alter the severity of age-related osteoarthritis. Age (Dordr) (2014) 0.78